Forte Biosciences, INC. (FBRX) — SC 13D/A Filings

All SC 13D/A filings from Forte Biosciences, INC.. Browse 4 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (4)

Camac Fund Ups Stake in Forte Biosciences — Jun 17, 2024 Risk: medium
Camac Fund, LP, through its filing on June 17, 2024, has amended its Schedule 13D regarding Forte Biosciences, Inc. The filing indicates a change in beneficial
BML Investment Partners Amends Forte Bio Stake (Amendment 5) — Jan 11, 2024
BML Investment Partners, L.P. filed an amended Schedule 13D/A on January 10, 2024, indicating a change in their beneficial ownership of Forte Biosciences, Inc.
Funicular Funds Amends Forte Bio Stake, Ma-Weaver Leads — Jan 9, 2024
Funicular Funds, LP, led by Jacob Ma-Weaver, has filed Amendment No. 5 to its Schedule 13D for Forte Biosciences, Inc. This amendment, triggered by an event on
Camac Fund Amends Forte Bio 13D, Adds ATG Capital Contact — Jan 5, 2024
Camac Fund, LP, a significant shareholder in Forte Biosciences, Inc., has filed an Amendment No. 1 to its Schedule 13D, indicating a change in its beneficial ow

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX